Skip to main content

Table 1 Trial level summary characteristics

From: Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials

  1. Shaded regions in the HARP-2 trial represent lack of raw data to derive APS-APII score or R
  2. IQR interquartile range, AUC area under the receiver operating characteristic curve, EQuOR extreme quartile odds ratio, (S)AE (serious) adverse events, APACHE II Acute Physiology And Chronic Health Evaluation II, APS-APII Acute Physiology Score from APACHE II, R risk of death calculated from APACHE II
Back to article page

Critical Care

ISSN: 1364-8535